Northeast Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate
Northeast Pharmaceutical Group Co Ltd cash flow reinvestment rate. Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥11.48 Million (capex CN¥11.48 Million ) from operating cash flow of CN¥274.09 Million. Explore Northeast Pharmaceutical Group Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Northeast Pharmaceutical Group Co Ltd (1999–2025)
Cash flow reinvestment rate of Northeast Pharmaceutical Group Co Ltd from 1999 to 2025. Historical reinvestment intensity for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. Explore Northeast Pharmaceutical Group Co Ltd (000597) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Northeast Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Northeast Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Northeast Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see how efficiently does Northeast Pharmaceutical Group Co Ltd generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | CN¥100.65 Million | CN¥1.11 Billion | CN¥97.78 Million | ▼ -84.4% |
| 2024 | 0.58x | CN¥443.39 Million | CN¥758.76 Million | CN¥159.43 Million | ▼ -26.0% |
| 2023 | 0.79x | CN¥463.40 Million | CN¥586.75 Million | CN¥235.43 Million | ▲ +74.9% |
| 2022 | 0.45x | CN¥500.47 Million | CN¥1.11 Billion | CN¥244.13 Million | ▲ +148.3% |
| 2021 | 0.18x | CN¥135.71 Million | CN¥746.51 Million | CN¥119.81 Million | ▼ -75.1% |
| 2020 | 0.73x | CN¥416.28 Million | CN¥570.92 Million | CN¥400.38 Million | ▲ +4.9% |
| 2019 | 0.70x | CN¥245.06 Million | CN¥352.60 Million | CN¥229.17 Million | ▼ -65.9% |
| 2018 | 2.04x | CN¥581.64 Million | CN¥285.09 Million | CN¥565.74 Million | ▲ +10.2% |
| 2016 | 1.85x | CN¥712.04 Million | CN¥384.51 Million | CN¥177.01 Million | ▼ -74.2% |
| 2015 | 7.18x | CN¥716.04 Million | CN¥99.70 Million | CN¥346.04 Million | ▼ -36.6% |
| 2014 | 11.33x | CN¥532.27 Million | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥178.90 Million | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥473.93 Million | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥862.78 Million | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥359.27 Million | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥87.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥103.66 Million | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥61.14 Million | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥87.46 Million | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥38.07 Million | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥46.57 Million | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥12.18 Million | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥9.41 Million | CN¥54.62 Million | CN¥9.41 Million | — |